Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
XTalks
FEBRUARY 5, 2024
Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data. Why it did so well: Darzalex was the first human anti-CD38 monoclonal antibody approved by the FDA for multiple myeloma. Price of Revlimid: A supply of 28 oral 2.5 mg capsules is $24,576.
Let's personalize your content